Loss of Wilms tumor 1 protein is a marker for apoptosis in response to replicative stress in leukemic cells

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Archives of Toxicology

• Publication date

  2018-03-27

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00204-018-2202-3PMID 29589053
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• WT1 protein is cleaved by caspase-3 in apoptotic leukemic cells

  2018influential reference
• Wilms' tumour 1 (WT1) in development, homeostasis and disease

  2017cited by this paper
• Assessment of HDACi-Induced Cytotoxicity.

  2017influential reference
• How to Distinguish Between the Activity of HDAC1-3 and HDAC6 with Western Blot.

  2017cited by this paper
• Dysfunction of the WT1-MEG3 signaling promotes AML leukemogenesis via p53-dependent and -independent pathways

  2017cited by this paper
• Interstrand Crosslink Repair as a Target for HDAC Inhibition.

  2017cited by this paper
• Histone deacetylase inhibitors induce proteolysis of activated CDC42-associated kinase-1 in leukemic cells

  2016cited by this paper
• Wilms tumor 1 mutations in the pathogenesis of acute myeloid leukemia

  2016cited by this paper
• WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation.

  2015cited by this paper
• A systematic review of known mechanisms of hydroxyurea-induced fetal hemoglobin for treatment of sickle cell disease

  2015influential reference
• Exploiting replicative stress to treat cancer

  2015influential reference
• Targeting extrinsic apoptosis in cancer: Challenges and opportunities.

  2015influential reference
• WT1-mediated repression of the proapoptotic transcription factor ZNF224 is triggered by the BCR-ABL oncogene

  2015cited by this paper
• Exogenous expression of WT1 gene influences U937 cell biological behaviors and activates MAPK and JAK-STAT signaling pathways.

  2014cited by this paper
• Caspase-8-mediated PAR-4 cleavage is required for TNFα-induced apoptosis

  2014cited by this paper
• DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia.

  2014cited by this paper
• WT1 Interacts with MAD2 and Regulates Mitotic Checkpoint Function

  2014cited by this paper
• The Wilms' tumor suppressor WT1 enhances CD95L expression and promotes activation‐induced cell death in leukemic T cells

  2014cited by this paper
• Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy

  2013influential reference
• Role of WT1-ZNF224 interaction in the expression of apoptosis-regulating genes.

  2013cited by this paper
• Chronic myelomonocytic leukemia: myelodysplastic or myeloproliferative?

  2013cited by this paper
• ATR prohibits replication catastrophe by preventing global exhaustion of RPA.

  2013influential reference
• WT1 expression as a marker of minimal residual disease predicts outcome in acute myeloid leukemia when measured post-consolidation.

  2012cited by this paper
• Hydroxyurea: a key player in cancer chemotherapy

  2012cited by this paper
• Doxorubicin induces the DNA damage response in cultured human mesenchymal stem cells

  2012cited by this paper
• The Transcription Factor Wilms Tumor 1 Confers Resistance in Myeloid Leukemia Cells against the Proapoptotic Therapeutic Agent TRAIL (Tumor Necrosis Factor α-related Apoptosis-inducing Ligand) by Regulating the Antiapoptotic Protein Bcl-xL*

  2012cited by this paper
• Role of hTERT and WT1 gene expression in disease progression and imatinib responsiveness of patients with BCR–ABL positive chronic myeloid leukemia

  2011cited by this paper
• High expression of IGFBP2 is associated with chemoresistance in adult acute myeloid leukemia.

  2011cited by this paper
• Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11.

  2011cited by this paper
• Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene

  2011influential reference
• NFκB/p53 crosstalk-a promising new therapeutic target.

  2011cited by this paper
• High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia.

  2011cited by this paper
• WT1 overexpression at diagnosis may predict favorable outcome in patients with de novo non-M3 acute myeloid leukemia

  2011cited by this paper
• The Wilms' Tumor Suppressor Protein WT1 Is Processed by the Serine Protease HtrA2/Omi

  2010influential reference
• Early reduction of WT1 transcripts during induction chemotherapy predicts for longer disease free and overall survival in acute myeloid leukemia

  2010cited by this paper
• Heat shock protein 90 regulates the expression of Wilms tumor 1 protein in myeloid leukemias.

  2010cited by this paper
• Ubiquitin conjugase UBCH8 targets active FMS-like tyrosine kinase 3 for proteasomal degradation

  2010cited by this paper
• Assessment of minimal residual disease in acute myeloid leukemia

  2010cited by this paper
• TSA downregulates Wilms tumor gene 1 (Wt1) expression at multiple levels

  2008cited by this paper
• Histone deacetylase inhibitors and hydroxyurea modulate the cell cycle and cooperatively induce apoptosis

  2008cited by this paper
• Mimicking the BH3 domain to kill cancer cells

  2008influential reference
• The role of the Wilms tumour gene (WT1) in normal and malignant haematopoiesis

  2007influential reference
• The Wilms’ tumor gene WT1-GFP knock-in mouse reveals the dynamic regulation of WT1 expression in normal and leukemic hematopoiesis

  2007influential reference
• Deregulation of the Wilms' tumour gene 1 protein (WT1) by BCR/ABL1 mediates resistance to imatinib in human leukaemia cells

  2007cited by this paper
• The antiapoptotic gene A1/BFL1 is a WT1 target gene that mediates granulocytic differentiation and resistance to chemotherapy.

  2006influential reference
• Antiapoptotic function of 17AA(+)WT1 (Wilms' tumor gene) isoforms on the intrinsic apoptosis pathway

  2006cited by this paper
• High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia.

  2006cited by this paper
• WT1 Influences Apoptosis Through Transcriptional Regulation of Bcl-2 Family Members

  2006influential reference
• Disruption of WT1 gene expression and exon 5 splicing following cytotoxic drug treatment: antisense down-regulation of exon 5 alters target gene expression and inhibits cell survival.

  2004cited by this paper
• Comparative analysis of genes regulated by PML/RAR alpha and PLZF/RAR alpha in response to retinoic acid using oligonucleotide arrays.

  2003cited by this paper
• Comparative Analysis of Genes Regulated by PML/RARα and PLZF/RARα in Response to Retinoic Acid Using Oligonucleotide Arrays

  2003cited by this paper
• Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR

  2002cited by this paper
• Negative regulation of bcl-2 expression by p53 in hematopoietic cells

  2001cited by this paper
• The Wilms tumor suppressor WT1 directs stage‐specific quiescence and differentiation of human hematopoietic progenitor cells

  2001cited by this paper
• Overexpression of murine WT1 + / + and - / - isoforms has no effect on chemoresistance but delays differentiation in the K562 leukemia cell line.

  2000cited by this paper
• DNA Double-stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139*

  1998cited by this paper
• High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome.

  1997cited by this paper
• Apoptosis induced by erythroid differentiation of human leukemia cell lines is inhibited by Bcl-XL.

  1996cited by this paper
• Regulation and function of Bcl-2 during differentiation-induced cell death in HL-60 promyelocytic cells.

  1995cited by this paper
• bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells.

  1992cited by this paper
• Establishment of human ampullary cell cultures.

  1989cited by this paper

• Identifizierung eines Moleküls, das den Abbau der aktivierten Checkpoint‐Kinase‐1 auslöst und Charakterisierung der nicht‐katalytischen Funktionen von Checkpoint‐Kinase‐1 in Tumorzellen

  2025cites this paper
• Identification of a Proteolysis‐Targeting‐Chimera that Addresses Activated Checkpoint Kinase‐1 Reveals its Non‐Catalytic Functions in Tumor Cells

  2025cites this paper
• Multifaceted functions of the Wilms tumor 1 protein: From its expression in various malignancies to targeted therapy

  2024cites this paper
• NOXA Accentuates Apoptosis Induction by a Novel Histone Deacetylase Inhibitor

  2023cites this paper
• Leukemia cells accumulate zinc for oncofusion protein stabilization.

  2023cites this paper
• Identification of HDAC10 Inhibitors that Modulate Autophagy-Related Proteins in Transformed Cells

  2022cites this paper
• Identification of histone deacetylase 10 (HDAC10) inhibitors that modulate autophagy in transformed cells.

  2022cites this paper
• Identification of a highly efficient dual type I/II FMS-like tyrosine kinase inhibitor that disrupts the growth of leukemic cells.

  2021cites this paper
• Class 1 Histone Deacetylases and Ataxia-Telangiectasia Mutated Kinase Control the Survival of Murine Pancreatic Cancer Cells upon dNTP Depletion

  2021cites this paper
• Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3

  2021cites this paper
• Oncogenic Kinase Cascades Induce Molecular Mechanisms That Protect Leukemic Cell Models from Lethal Effects of De Novo dNTP Synthesis Inhibition

  2021influential citation
• HDAC3 Activity is Essential for Human Leukemic Cell Growth and the Expression of β-catenin, MYC, and WT1

  2019cites this paper
• Survivin antagonizes chemotherapy-induced cell death of colorectal cancer cells

  2018cites this paper